At week 72, 36.8% of people treated with semaglutide demonstrated an improvement in liver fibrosis without worsening of inflammation, compared with 22.4% in the placebo group
On the other hand, it has been demonstrated that various phenolic antioxidants exhibit pro-oxidant properties at high doses[75]
Semaglutide for medical weight loss is a prescription medication specifically designed to help individuals achieve and maintain weight loss
Participants receiving tirzepatide achieved greater weight-loss milestones than those receiving semaglutide [3]
It is unknown whether ZEPBOUND causes thyroid C-cell tumors, including medullary thyroid carcinoma (MTC), in humans as the human relevance of tirzepatide-induced rodent thyroid C-cell tumors has not been determined (5.1, 13.1)
When you talk to the office about scheduling a consultation, ask them for an email address to send your pictures to so that the physician can look them over before your consultation appointment